Annual Operating Profit
-$13.06 M
+$9.68 M+42.57%
December 31, 2023
Summary
- As of February 7, 2025, FENC annual operating income is -$13.06 million, with the most recent change of +$9.68 million (+42.57%) on December 31, 2023.
- During the last 3 years, FENC annual operating profit has risen by +$4.83 million (+26.99%).
- FENC annual operating profit is now -713.28% below its all-time high of -$1.61 million, reached on June 30, 2000.
Performance
FENC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$5.22 M
-$184.00 K-3.65%
September 30, 2024
Summary
- As of February 7, 2025, FENC quarterly operating income is -$5.22 million, with the most recent change of -$184.00 thousand (-3.65%) on September 30, 2024.
- Over the past year, FENC quarterly operating profit has dropped by -$184.00 thousand (-3.65%).
- FENC quarterly operating profit is now -138.06% below its all-time high of $13.72 million, reached on March 31, 2024.
Performance
FENC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$1.57 M
-$4.13 M-72.44%
September 30, 2024
Summary
- As of February 7, 2025, FENC TTM operating income is $1.57 million, with the most recent change of -$4.13 million (-72.44%) on September 30, 2024.
- Over the past year, FENC TTM operating profit has dropped by -$4.13 million (-72.44%).
- FENC TTM operating profit is now -74.13% below its all-time high of $6.08 million, reached on March 31, 2024.
Performance
FENC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
FENC Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.6% | -3.6% | -72.4% |
| 3 y3 years | +27.0% | +2.2% | +106.4% |
| 5 y5 years | -25.4% | +2.2% | +106.4% |
FENC Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.6% | -138.1% | +34.4% | -74.1% | +106.4% |
| 5 y | 5-year | -0.4% | +42.6% | -138.1% | +34.4% | -74.1% | +106.4% |
| alltime | all time | -713.3% | +42.6% | -138.1% | +34.4% | -74.1% | +106.4% |
Fennec Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.22 M(+3.7%) | $1.57 M(-72.4%) |
| Jun 2024 | - | -$5.04 M(-136.7%) | $5.71 M(-6.1%) |
| Mar 2024 | - | $13.72 M(-826.9%) | $6.08 M(-146.8%) |
| Dec 2023 | -$13.06 M(-42.6%) | -$1.89 M(+73.4%) | -$12.98 M(-25.0%) |
| Sep 2023 | - | -$1.09 M(-76.7%) | -$17.30 M(-28.4%) |
| Jun 2023 | - | -$4.67 M(-12.7%) | -$24.18 M(-1.4%) |
| Mar 2023 | - | -$5.34 M(-13.9%) | -$24.52 M(+7.9%) |
| Dec 2022 | -$22.74 M(+32.0%) | -$6.21 M(-22.1%) | -$22.73 M(+9.6%) |
| Sep 2022 | - | -$7.96 M(+59.0%) | -$20.73 M(+22.4%) |
| Jun 2022 | - | -$5.01 M(+41.0%) | -$16.94 M(+6.9%) |
| Mar 2022 | - | -$3.55 M(-15.5%) | -$15.85 M(-8.0%) |
| Dec 2021 | -$17.22 M(-3.7%) | -$4.21 M(+0.8%) | -$17.22 M(+5.3%) |
| Sep 2021 | - | -$4.17 M(+6.5%) | -$16.36 M(-9.3%) |
| Jun 2021 | - | -$3.92 M(-20.4%) | -$18.05 M(-4.9%) |
| Mar 2021 | - | -$4.92 M(+47.1%) | -$18.97 M(+6.1%) |
| Dec 2020 | -$17.89 M(+37.5%) | -$3.35 M(-42.9%) | -$17.89 M(-1.7%) |
| Sep 2020 | - | -$5.86 M(+20.9%) | -$18.19 M(+28.1%) |
| Jun 2020 | - | -$4.84 M(+26.3%) | -$14.20 M(+0.2%) |
| Mar 2020 | - | -$3.83 M(+5.0%) | -$14.16 M(+8.9%) |
| Dec 2019 | -$13.01 M(+25.0%) | -$3.65 M(+96.1%) | -$13.01 M(+4.4%) |
| Sep 2019 | - | -$1.86 M(-61.3%) | -$12.46 M(-7.3%) |
| Jun 2019 | - | -$4.81 M(+79.6%) | -$13.45 M(+19.0%) |
| Mar 2019 | - | -$2.68 M(-13.7%) | -$11.30 M(+8.5%) |
| Dec 2018 | -$10.41 M(+49.7%) | -$3.10 M(+9.0%) | -$10.41 M(+6.0%) |
| Sep 2018 | - | -$2.85 M(+6.9%) | -$9.82 M(+7.2%) |
| Jun 2018 | - | -$2.67 M(+48.8%) | -$9.16 M(+14.9%) |
| Mar 2018 | - | -$1.79 M(-28.8%) | -$7.97 M(+14.7%) |
| Dec 2017 | -$6.95 M(+142.1%) | -$2.52 M(+15.1%) | -$6.95 M(+24.5%) |
| Sep 2017 | - | -$2.19 M(+47.8%) | -$5.58 M(+41.0%) |
| Jun 2017 | - | -$1.48 M(+91.8%) | -$3.96 M(+24.2%) |
| Mar 2017 | - | -$771.00 K(-32.7%) | -$3.19 M(+11.0%) |
| Dec 2016 | -$2.87 M(+51.9%) | -$1.15 M(+103.2%) | -$2.87 M(+26.1%) |
| Sep 2016 | - | -$564.00 K(-20.2%) | -$2.28 M(+11.0%) |
| Jun 2016 | - | -$707.00 K(+55.7%) | -$2.05 M(+8.4%) |
| Mar 2016 | - | -$454.00 K(-17.6%) | -$1.89 M(+0.1%) |
| Dec 2015 | -$1.89 M(-34.3%) | -$551.00 K(+63.0%) | -$1.89 M(-11.3%) |
| Sep 2015 | - | -$338.00 K(-38.4%) | -$2.13 M(-11.7%) |
| Jun 2015 | - | -$549.00 K(+21.5%) | -$2.41 M(-13.6%) |
| Mar 2015 | - | -$452.00 K(-42.9%) | -$2.79 M(-3.0%) |
| Dec 2014 | -$2.88 M(+49.0%) | -$791.00 K(+27.8%) | -$2.88 M(+15.0%) |
| Sep 2014 | - | -$619.00 K(-33.4%) | -$2.50 M(+29.4%) |
| Jun 2014 | - | -$930.00 K(+73.2%) | -$1.93 M(+0.2%) |
| Mar 2014 | - | -$537.00 K(+29.1%) | -$1.93 M(0.0%) |
| Dec 2013 | -$1.93 M(-46.7%) | -$416.00 K(+715.7%) | -$1.93 M(-26.8%) |
| Sep 2013 | - | -$51.00 K(-94.5%) | -$2.64 M(-18.0%) |
| Jun 2013 | - | -$927.00 K(+72.6%) | -$3.22 M(-9.1%) |
| Mar 2013 | - | -$537.00 K(-52.2%) | -$3.54 M(-2.2%) |
| Dec 2012 | -$3.62 M | -$1.12 M(+78.3%) | -$3.62 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$630.00 K(-49.6%) | -$3.40 M(-8.5%) |
| Jun 2012 | - | -$1.25 M(+102.9%) | -$3.71 M(+22.3%) |
| Mar 2012 | - | -$616.00 K(-31.7%) | -$3.03 M(-11.8%) |
| Dec 2011 | -$3.44 M(-25.3%) | -$902.00 K(-4.4%) | -$3.44 M(+2.6%) |
| Sep 2011 | - | -$944.00 K(+65.0%) | -$3.35 M(+0.8%) |
| Jun 2011 | - | -$572.00 K(-44.0%) | -$3.33 M(-36.8%) |
| Mar 2011 | - | -$1.02 M(+25.1%) | -$5.26 M(+14.2%) |
| Dec 2010 | -$4.60 M(+62.7%) | -$816.00 K(-11.0%) | -$4.60 M(+39.4%) |
| Sep 2010 | - | -$917.00 K(-63.4%) | -$3.30 M(+34.3%) |
| Jun 2010 | - | -$2.50 M(+584.4%) | -$2.46 M(+168.6%) |
| Mar 2010 | - | -$366.00 K(-175.5%) | -$916.00 K(-63.4%) |
| Dec 2009 | -$2.83 M(-79.6%) | $485.00 K(-755.4%) | -$2.50 M(-55.5%) |
| Sep 2009 | - | -$74.00 K(-92.3%) | -$5.63 M(-36.4%) |
| Jun 2009 | - | -$961.00 K(-50.8%) | -$8.85 M(-22.4%) |
| Mar 2009 | - | -$1.95 M(-26.1%) | -$11.40 M(-17.9%) |
| Dec 2008 | -$13.89 M(-2.1%) | -$2.64 M(-20.0%) | -$13.89 M(-3.7%) |
| Sep 2008 | - | -$3.30 M(-6.0%) | -$14.43 M(-1.1%) |
| Jun 2008 | - | -$3.51 M(-20.9%) | -$14.58 M(+0.5%) |
| Mar 2008 | - | -$4.44 M(+39.5%) | -$14.51 M(+2.3%) |
| Dec 2007 | -$14.19 M(-25.6%) | -$3.18 M(-8.0%) | -$14.19 M(-21.2%) |
| Sep 2007 | - | -$3.46 M(+0.5%) | -$18.02 M(-6.8%) |
| Jun 2007 | - | -$3.44 M(-16.4%) | -$19.33 M(-2.7%) |
| Mar 2007 | - | -$4.12 M(-41.3%) | -$19.87 M(+4.2%) |
| Dec 2006 | -$19.06 M(+3.9%) | -$7.01 M(+46.9%) | -$19.06 M(+10.6%) |
| Sep 2006 | - | -$4.77 M(+19.9%) | -$17.24 M(-0.2%) |
| Jun 2006 | - | -$3.98 M(+20.3%) | -$17.28 M(-5.3%) |
| Mar 2006 | - | -$3.31 M(-36.3%) | -$18.24 M(-0.6%) |
| Dec 2005 | -$18.35 M(+94.7%) | -$5.19 M(+8.1%) | -$18.35 M(+39.4%) |
| Sep 2005 | - | -$4.80 M(-2.8%) | -$13.16 M(+14.3%) |
| Jun 2005 | - | -$4.94 M(+44.6%) | -$11.52 M(+21.5%) |
| Mar 2005 | - | -$3.42 M(+8.2%) | -$9.48 M(-13.3%) |
| Sep 2004 | - | -$3.16 M(+8.7%) | -$10.93 M(+16.2%) |
| Jun 2004 | -$9.42 M(+39.9%) | -$2.91 M(+7.3%) | -$9.41 M(+6.5%) |
| Mar 2004 | - | -$2.71 M(+25.4%) | -$8.84 M(+10.1%) |
| Dec 2003 | - | -$2.16 M(+31.9%) | -$8.03 M(+13.9%) |
| Sep 2003 | - | -$1.64 M(-29.8%) | -$7.05 M(+7.5%) |
| Jun 2003 | -$6.73 M(+66.6%) | -$2.33 M(+22.9%) | -$6.56 M(+14.7%) |
| Mar 2003 | - | -$1.90 M(+61.4%) | -$5.71 M(+21.0%) |
| Dec 2002 | - | -$1.18 M(+2.7%) | -$4.72 M(+11.4%) |
| Sep 2002 | - | -$1.15 M(-23.2%) | -$4.24 M(+4.7%) |
| Jun 2002 | -$4.04 M(+52.6%) | -$1.49 M(+64.1%) | -$4.05 M(-22.2%) |
| Mar 2002 | - | -$909.60 K(+30.8%) | -$5.21 M(+21.2%) |
| Dec 2001 | - | -$695.30 K(-27.1%) | -$4.30 M(+3.3%) |
| Sep 2001 | - | -$953.30 K(-64.0%) | -$4.16 M(+29.7%) |
| Jun 2001 | -$2.65 M(+65.0%) | -$2.65 M(<-9900.0%) | -$3.21 M(+474.0%) |
| Mar 2001 | - | $0.00(-100.0%) | -$558.80 K(0.0%) |
| Dec 2000 | - | -$558.80 K(<-9900.0%) | -$558.80 K(<-9900.0%) |
| Sep 2000 | - | $0.00 | $0.00 |
| Jun 2000 | -$1.61 M | - | - |
FAQ
- What is Fennec Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual operating profit year-on-year change?
- What is Fennec Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly operating profit year-on-year change?
- What is Fennec Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals TTM operating profit year-on-year change?
What is Fennec Pharmaceuticals annual operating income?
The current annual operating profit of FENC is -$13.06 M
What is the all time high annual operating profit for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual operating income is -$1.61 M
What is Fennec Pharmaceuticals annual operating profit year-on-year change?
Over the past year, FENC annual operating income has changed by +$9.68 M (+42.57%)
What is Fennec Pharmaceuticals quarterly operating income?
The current quarterly operating profit of FENC is -$5.22 M
What is the all time high quarterly operating profit for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly operating income is $13.72 M
What is Fennec Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, FENC quarterly operating income has changed by -$184.00 K (-3.65%)
What is Fennec Pharmaceuticals TTM operating income?
The current TTM operating profit of FENC is $1.57 M
What is the all time high TTM operating profit for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high TTM operating income is $6.08 M
What is Fennec Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, FENC TTM operating income has changed by -$4.13 M (-72.44%)